BR112015004503A2 - liga de magnésio ultrapuro com taxa de degradação ajustável - Google Patents

liga de magnésio ultrapuro com taxa de degradação ajustável

Info

Publication number
BR112015004503A2
BR112015004503A2 BR112015004503A BR112015004503A BR112015004503A2 BR 112015004503 A2 BR112015004503 A2 BR 112015004503A2 BR 112015004503 A BR112015004503 A BR 112015004503A BR 112015004503 A BR112015004503 A BR 112015004503A BR 112015004503 A2 BR112015004503 A2 BR 112015004503A2
Authority
BR
Brazil
Prior art keywords
alloy
less
elements
remainder
matrix
Prior art date
Application number
BR112015004503A
Other languages
English (en)
Other versions
BR112015004503B1 (pt
Inventor
Loeffler Joerg
Uggowitzer Peter
Beck Stefan
Imwinkelried Thomas
Original Assignee
Synthes Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthes Gmbh filed Critical Synthes Gmbh
Publication of BR112015004503A2 publication Critical patent/BR112015004503A2/pt
Publication of BR112015004503B1 publication Critical patent/BR112015004503B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/04—Metals or alloys
    • A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
    • A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws, setting implements or the like
    • A61B17/68—Internal fixation devices, including fasteners and spinal fixators, even if a part thereof projects from the skin
    • A61B17/84—Fasteners therefor or fasteners being internal fixation devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02—Inorganic materials
    • A61L31/022—Metals or alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B21—MECHANICAL METAL-WORKING WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL
    • B21C—MANUFACTURE OF METAL SHEETS, WIRE, RODS, TUBES OR PROFILES, OTHERWISE THAN BY ROLLING; AUXILIARY OPERATIONS USED IN CONNECTION WITH METAL-WORKING WITHOUT ESSENTIALLY REMOVING MATERIAL
    • B21C23/00—Extruding metal; Impact extrusion
    • B21C23/002—Extruding materials of special alloys so far as the composition of the alloy requires or permits special extruding methods of sequences
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C23/00—Alloys based on magnesium
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C23/00—Alloys based on magnesium
    • C22C23/04—Alloys based on magnesium with zinc or cadmium as the next major constituent
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
    • C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
    • C22F1/06—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working of magnesium or alloys based thereon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mechanical Engineering (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Powder Metallurgy (AREA)

Abstract

abstract an alloy and an implant having a three-dimensional structure based on such alloy. the alloy comprises a monophasic mgzn alloy containing from 2.0 wt. % zn to 6 wt. % zn, having less than 0.001 wt. % of one or more other elements with the remainder being mg. in some embodiments, the alloy is substantially free of microgalvanic elements. in some embodiments, the alloy includes a mgznca alloy containing nanosized precipitates being less noble than the mg matrix alloy and having a zn content ranging from 3.0 wt. % zn to 6 wt. % zn and a calcium content ranging from 0.0005 wt. % to 1.0 wt. %, having less than 0.001 wt. % of one or more other elements with the remainder being mg. in other embodiments, the alloy includes a mgznca alloy containing nanosized precipitates being less noble than the mg matrix alloy, a plurality of nanosized precipitates being more noble than the mg matrix and having a zn content ranging from 3.0 wt. % zn to 6 wt. % zn, a calcium content ranging from 0.0005 wt. % to 1.0 wt. %, having less than 0.001 wt. % of one or more other elements with the remainder being mg. tradução do resumo resumo patente de invenção: "liga de magnésio ultrapuro com taxa de degradação ajustável". trata-se de uma liga e um implante que tem uma estrutura tridimensional com base em tal liga. a liga compreende uma liga de mgzn monofásica contendo de 2,0% em peso de zn a 6% em peso de zn, que tem menos que 0,001% em peso de um ou mais outros elementos em que o restante é mg. em algumas modalidades, a liga é substancialmente isenta de elementos microgalvânicos. em algumas modalidades, a liga inclui uma liga de mgznca contendo precipitados nanodimensionados que são menos nobres que a liga de matriz de mg e que têm um teor de zn na faixa de 3,0% em peso de zn a 6% em peso de zn e um teor de cálcio na faixa de 0,0005% em peso a 1,0% em peso, tendo menos que 0,001% em peso de um ou mais outros elementos, em que o restante é mg. em outras modalidades, a liga inclui uma liga de mgznca contendo precipitados nanodimensionados que são menos nobres que a liga de matriz de mg, em que uma pluralidade de precipitados nanodimensionados é mais nobre que a matriz de mg e tem um teor de zn na faixa de 3,0% em peso de zn a 6% em peso de zn, um teor de cálcio na faixa de 0,0005% em peso a 1,0% em peso, tendo menos que 0,001% em peso de um ou mais outros elementos, em que o restante é mg.
BR112015004503-0A 2012-08-31 2013-08-29 composição de liga de mgznca, seu método de produção e implante BR112015004503B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261695621P 2012-08-31 2012-08-31
US61/695,621 2012-08-31
US13/827,008 US9469889B2 (en) 2012-08-31 2013-03-14 Ultrapure magnesium alloy with adjustable degradation rate
US13/827,008 2013-03-14
PCT/US2013/057294 WO2014036262A1 (en) 2012-08-31 2013-08-29 Ultrapure magnesium alloy with adjustable degradation rate

Publications (2)

Publication Number Publication Date
BR112015004503A2 true BR112015004503A2 (pt) 2017-07-04
BR112015004503B1 BR112015004503B1 (pt) 2021-03-02

Family

ID=49162261

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015004503-0A BR112015004503B1 (pt) 2012-08-31 2013-08-29 composição de liga de mgznca, seu método de produção e implante

Country Status (10)

Country Link
US (2) US9469889B2 (pt)
EP (1) EP2890824B1 (pt)
JP (2) JP6752575B2 (pt)
KR (1) KR102275471B1 (pt)
CN (2) CN104755644A (pt)
BR (1) BR112015004503B1 (pt)
CA (1) CA2883268C (pt)
IN (1) IN2015DN01751A (pt)
TW (1) TWI640638B (pt)
WO (1) WO2014036262A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10895000B2 (en) 2012-06-26 2021-01-19 Biotronik Ag Magnesium alloy, method for the production thereof and use thereof
BR112014032649A2 (pt) 2012-06-26 2017-06-27 Biotronik Ag liga de magnésio-zinco-cálcio, método de produção da mesma e seu uso
US20150080998A1 (en) 2012-06-26 2015-03-19 Biotronik Ag Magnesium-aluminum-zinc alloy, method for the production thereof and use thereof
CN109022980A (zh) 2012-06-26 2018-12-18 百多力股份公司 镁合金、其生产方法及其用途
US9469889B2 (en) 2012-08-31 2016-10-18 DePuy Synthes Products, Inc. Ultrapure magnesium alloy with adjustable degradation rate
EP2971206A1 (en) 2013-03-14 2016-01-20 DePuy Synthes Products, Inc. Magnesium alloy with adjustable degradation rate
US9593397B2 (en) 2013-03-14 2017-03-14 DePuy Synthes Products, Inc. Magnesium alloy with adjustable degradation rate
US20160206788A1 (en) * 2013-06-12 2016-07-21 The Regents Of The University Of California Biomimetic interfaces for biodegradable metallic implants
WO2016033312A1 (en) * 2014-08-27 2016-03-03 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Magnesium enhanced/induced bone formation
TWI610651B (zh) * 2014-11-20 2018-01-11 財團法人金屬工業研究發展中心 鎂合金縫合釘
CN105568103A (zh) * 2016-01-04 2016-05-11 青岛工学院 一种可降解生物医用镁合金
CN107227422A (zh) * 2016-03-25 2017-10-03 武汉理工大学 一种高强度盐水可溶性镁合金材料及其制备方法
KR20170115429A (ko) 2016-04-07 2017-10-17 랩앤피플주식회사 생체분해성 금속을 이용한 마이크로 니들
WO2017176077A1 (ko) * 2016-04-07 2017-10-12 랩앤피플주식회사 생체분해성 금속을 이용한 마이크로 니들
KR101888091B1 (ko) * 2016-10-31 2018-08-14 유앤아이 주식회사 생체분해 마그네슘 합금 및 그 제조방법
WO2018109947A1 (ja) * 2016-12-16 2018-06-21 三協立山株式会社 マグネシウム合金の製造方法およびマグネシウム合金
CN107236886B (zh) * 2017-07-10 2018-09-07 太原理工大学 一种医用可降解高强韧耐蚀多元Mg-Zn-Y-Ca-Zr合金及其制备方法
CN107190192B (zh) * 2017-07-10 2018-10-02 太原理工大学 一种可吸收生物医用高强韧耐蚀镁合金材料及其制备方法
CN107523732B (zh) * 2017-08-15 2019-04-05 太原科技大学 一种含Na快速降解镁合金及其制备方法
CN108425051A (zh) * 2018-03-29 2018-08-21 江苏理工学院 一种生物医用Mg-Sn-Zn-Ca镁合金及其制备方法
CN109112377B (zh) * 2018-11-09 2020-06-02 吉林大学 一种耐蚀生物医用镁合金及其制备方法和应用
CN110438380B (zh) * 2019-08-13 2021-02-26 中南大学 一种耐热阻燃镁合金及其形变热处理方法
EP4022104A4 (en) * 2019-08-26 2023-09-27 Ohio State Innovation Foundation OBJECTS BASED ON MAGNESIUM ALLOY AND ASSOCIATED METHODS OF MANUFACTURING AND USE
CN110604632A (zh) * 2019-10-21 2019-12-24 中国人民解放军南部战区海军第一医院 生物可降解美容提拉线及其制备方法
JPWO2021215543A1 (pt) * 2020-04-21 2021-10-28
JP2021079133A (ja) * 2021-02-10 2021-05-27 キュースリー メディカル デヴァイシズ リミテッドＱ３ Ｍｅｄｉｃａｌ Ｄｅｖｉｃｅｓ Ｌｉｍｉｔｅｄ 生体分解性支持デバイス

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320055A (en) 1964-08-19 1967-05-16 Dow Chemical Co Magnesium-base alloy
AU2002950563A0 (en) * 2002-08-02 2002-09-12 Commonwealth Scientific And Industrial Research Organisation Age-Hardenable, Zinc-Containing Magnesium Alloys
CN1743486A (zh) 2004-08-31 2006-03-08 唐智荣 镁元素为基质的合金及作为骨折内固定器的应用
CN100400114C (zh) * 2005-04-30 2008-07-09 中国科学院金属研究所 可控降解速率的生物医用植入材料及其应用
US8034101B2 (en) 2005-11-16 2011-10-11 National Institute For Materials Science Magnesium-based biodegradable metallic material
CN100368028C (zh) 2005-12-22 2008-02-13 上海交通大学 生物体内可吸收的Mg-Zn两元镁合金材料
CN1792383A (zh) * 2005-12-22 2006-06-28 上海交通大学 生物体内可吸收的Mg－Zn－Ca三元镁合金材料
DE102006015457A1 (de) 2006-03-31 2007-10-04 Biotronik Vi Patent Ag Magnesiumlegierung und dazugehöriges Herstellungsverfahren
US20100075162A1 (en) 2006-09-22 2010-03-25 Seok-Jo Yang Implants comprising biodegradable metals and method for manufacturing the same
KR101289122B1 (ko) 2008-03-18 2013-07-23 한국보건산업진흥원 생체분해성 마그네슘계 합금으로 다공성 구조체의 기공이충진된 복합재 임플란트 및 이의 제조방법
JP5467294B2 (ja) 2008-06-05 2014-04-09 独立行政法人産業技術総合研究所 易成形性マグネシウム合金板材及びその作製方法
CN102057068B (zh) 2008-06-06 2012-08-29 斯恩蒂斯有限公司 可再吸收的镁合金
CN101629260A (zh) 2008-07-18 2010-01-20 中国科学院金属研究所 医用可吸收Mg-Zn-Mn-Ca镁合金
JP5784005B2 (ja) 2009-04-22 2015-09-24 ユー アンド アイ コーポレーション 生分解性インプラント及びその製造方法
JP5593812B2 (ja) * 2009-04-30 2014-09-24 Ｊｆｅスチール株式会社 Ｚｎ−Ｍｇ系めっき鋼板およびその製造方法
CN101658691B (zh) 2009-07-31 2013-03-13 哈尔滨工业大学 高纯度镁合金可吸收血管支架塑性加工制造方法
JP2013512069A (ja) 2009-12-07 2013-04-11 ユー アンド アイ コーポレーション インプラント
JP5894079B2 (ja) 2009-12-07 2016-03-23 ユー アンド アイ コーポレーション マグネシウム合金
AT510087B1 (de) 2010-07-06 2012-05-15 Ait Austrian Institute Of Technology Gmbh Magnesiumlegierung
CN101899600B (zh) 2010-08-13 2012-04-25 上海交通大学 骨科用镁合金内植入材料及其制备方法
JP5720926B2 (ja) 2010-10-12 2015-05-20 住友電気工業株式会社 マグネシウム合金の線状体及びボルト、ナット並びにワッシャー
EP2629810A1 (en) * 2010-10-18 2013-08-28 Boston Scientific Scimed, Inc. Medical implant including a magnesium-based tie layer
WO2013107644A1 (de) 2012-01-19 2013-07-25 Eth Zurich Verfahren und vorrichtung zur vakuumdestillation von hochreinem magnesium
CN109022980A (zh) 2012-06-26 2018-12-18 百多力股份公司 镁合金、其生产方法及其用途
BR112014032649A2 (pt) 2012-06-26 2017-06-27 Biotronik Ag liga de magnésio-zinco-cálcio, método de produção da mesma e seu uso
US9469889B2 (en) 2012-08-31 2016-10-18 DePuy Synthes Products, Inc. Ultrapure magnesium alloy with adjustable degradation rate
EP2971206A1 (en) 2013-03-14 2016-01-20 DePuy Synthes Products, Inc. Magnesium alloy with adjustable degradation rate
US9593397B2 (en) 2013-03-14 2017-03-14 DePuy Synthes Products, Inc. Magnesium alloy with adjustable degradation rate

Also Published As

Publication number Publication date
JP6752575B2 (ja) 2020-09-09
US20140065009A1 (en) 2014-03-06
TWI640638B (zh) 2018-11-11
CN104755644A (zh) 2015-07-01
US9469889B2 (en) 2016-10-18
US20170000925A1 (en) 2017-01-05
EP2890824B1 (en) 2019-04-17
CN111304504A (zh) 2020-06-19
EP2890824A1 (en) 2015-07-08
BR112015004503B1 (pt) 2021-03-02
TW201422822A (zh) 2014-06-16
IN2015DN01751A (pt) 2015-05-29
US10213522B2 (en) 2019-02-26
CA2883268C (en) 2021-01-05
KR102275471B1 (ko) 2021-07-13
KR20150050586A (ko) 2015-05-08
JP2019049056A (ja) 2019-03-28
CA2883268A1 (en) 2014-03-06
JP2015532685A (ja) 2015-11-12
WO2014036262A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
BR112015004503A2 (pt) liga de magnésio ultrapuro com taxa de degradação ajustável
BR112015022632A2 (pt) liga de magnésio com taxa de degradação ajustável
BR112021006613A2 (pt) composições com deposição intensificada de agentes anticaspa solúveis em tensoativo
EA201291108A1 (ru) Фармацевтические композиции в виде эмульсии с низким содержанием масла, содержащие прогестоген
AR100925A1 (es) Composiciones orales que contienen fuentes de ión de zinc, estaño y fluoruro
BR112013007866A2 (pt) "espumas aquosas para combate ao fogo com teor de cloro reduzido".
BR112015014480A2 (pt) composições estáveis contendo íons metálicos
BR112015014006A2 (pt) composições de cuidado oral estáveis ao peróxido
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
PH12017502326B1 (en) Orodispersible dosage unit containing an estetrol component
BR112013020537A2 (pt) suspensão aquosa e pó de liberação prolongada que compreendem metilfenidato
MX347753B (es) Formulaciones resistentes al abuso.
BR112015004185A2 (pt) composições antiperspirantes em aerossol, produtos e métodos
BR112018074352A2 (pt) partículas de nanoalume contendo um agente de dimensionamento
MX2018003975A (es) Combinacion de glicosaminoglicanos y un agente antacido y sus composiciones.
CO6040038A1 (es) Composiciones de ciclopropeno
BR112018003781A2 (pt) chapa de aço chapeada
PH12014502512A1 (en) Topical pharmaceutical compositions comprising terbinafine and urea
BR112019006932A2 (pt) composições antimicrobianas
BR112015015137A2 (pt) estrutura à base de polietileno
AR100437A1 (es) Composiciones para el cuidado bucal
MX353099B (es) Metodo para producir particulas de polvo libre de poliamida impregnada con por lo menos un agente cosmetico o farmaceutico, y particulas de polvo libre de poliamida que tienen un contenido de por lo menos 25% en peso de por lo menos un agente cosmetico o farmaceutico diferente al agua.
BR112015014092A2 (pt) administração oral transmucosal de acetato de glatirâmer
BR112017000157A2 (pt) composições bucais anticálculo
BR112017005611A2 (pt) agente de suprimento energético lentamente digerível, composição de sacarídeos, produto de alimento ou de bebida, agente para uso no tratamento e prevenção de uma doença ou um sintoma, método para fornecer energia, método para tratar e/ou prevenir uma doença ou um sintoma, e, uso de uma composição de sacarídeos.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/08/2013, OBSERVADAS AS CONDICOES LEGAIS.